Common use of Disclosure Schedule References and SEC Document References Clause in Contracts

Disclosure Schedule References and SEC Document References. (a) The Parties agree that each section or subsection of the Allergan Disclosure Schedule or the AbbVie Disclosure Schedule, as applicable, shall be deemed to qualify the corresponding section or subsection of this Agreement, irrespective of whether or not any particular section or subsection of this Agreement specifically refers to the Allergan Disclosure Schedule or the AbbVie Disclosure Schedule, as applicable. The Parties further agree that (other than with respect to any items disclosed in Section 6.1(A)(k) of the Allergan Disclosure Schedule or Section 6.2(A)(h) of the AbbVie Disclosure Schedule, for which an explicit reference in any other section shall be required in order to apply to such other section) disclosure of any item, matter or event in any particular section or subsection of either the Allergan Disclosure Schedule or the AbbVie Disclosure Schedule shall be deemed disclosure with respect to any other section or subsection of the Allergan Disclosure Schedule or the AbbVie Disclosure Schedule, as applicable, to which the relevance of such disclosure would be reasonably apparent on its face, notwithstanding the omission of a cross-reference to such other section or subsections. (b) The Parties agree that in no event shall any disclosure contained in any part of any Allergan SEC Document or AbbVie SEC Document entitled “Risk Factors”, “Forward-Looking Statements”, “Cautionary Statement Regarding Forward-Looking Statements”, “Special Note Regarding Forward Looking Statements” or “Note Regarding Forward Looking Statements” or any other disclosures in any Allergan SEC Document or AbbVie SEC Document that are cautionary, predictive or forward-looking in nature be deemed to be an exception to (or a disclosure for purposes of or otherwise qualify) any representations and warranties of any Party contained in this Agreement.

Disclosure Schedule References and SEC Document References. (a) The Parties parties hereto agree that each section or subsection of the Allergan Company Disclosure Schedule or the AbbVie Parent Disclosure Schedule, as applicable, shall be deemed to qualify the corresponding section or subsection of this Agreement, irrespective of whether or not any particular section or subsection of this Agreement specifically refers to the Allergan Company Disclosure Schedule or the AbbVie Parent Disclosure Schedule, as applicable. The Parties parties hereto further agree that (other than with respect to any items disclosed in Section 6.1(A)(k) of the Allergan Disclosure Schedule or Section 6.2(A)(h) of the AbbVie Disclosure Schedule, for which an explicit reference in any other section shall be required in order to apply to such other section) disclosure of any item, matter or event in any particular section or subsection of either the Allergan Company Disclosure Schedule or the AbbVie Parent Disclosure Schedule shall be deemed disclosure with respect to any other section or subsection of the Allergan Company Disclosure Schedule or the AbbVie Parent Disclosure Schedule, as applicable, to which the relevance of such disclosure would be reasonably apparent on its faceapparent, notwithstanding the omission of a cross-reference to such other section or subsections. (b) The Parties parties hereto agree that in no event shall any disclosure contained in any part of any Allergan Company SEC Document or AbbVie Parent SEC Document entitled “Risk Factors”, “Forward-Looking Statements”, “Cautionary Statement Regarding Forward-Looking Statements”, “Special Note Regarding Forward Looking Statements” or “Note Regarding Forward Looking Statements” or any other disclosures in any Allergan Company SEC Document or AbbVie Parent SEC Document that are cautionary, predictive or forward-looking in nature be deemed to be an exception to (or a disclosure for purposes of or otherwise qualify) any representations and warranties of any Party party contained in this Agreement.

Disclosure Schedule References and SEC Document References. (a) The Parties parties hereto agree that each section or subsection of the Allergan Company Disclosure Schedule or the AbbVie Parent Disclosure Schedule, as applicable, shall be deemed to qualify the corresponding section or subsection of this Agreement, irrespective of whether or not any particular section or subsection of this Agreement specifically refers to the Allergan Company Disclosure Schedule or the AbbVie Parent Disclosure Schedule, as applicable. The Parties parties hereto further agree that (other than with respect to any items disclosed in Section 6.1(A)(k‎Section 4.19(a) of the Allergan Disclosure Schedule or Section 6.2(A)(h) of the AbbVie Company Disclosure Schedule, for which an explicit reference in any other section shall be required in order to apply to such other section) disclosure of any item, matter or event in any particular section or subsection of either the Allergan Company Disclosure Schedule or the AbbVie Parent Disclosure Schedule shall be deemed disclosure with respect to any other section or subsection of the Allergan Company Disclosure Schedule or the AbbVie Parent Disclosure Schedule, as applicable, to which the relevance of such disclosure would be reasonably apparent on its faceapparent, notwithstanding the omission of a cross-reference to such other section or subsections. (b) The Parties parties hereto agree that in no event shall any disclosure contained in any part of any Allergan Company SEC Document or AbbVie Parent SEC Document entitled “Risk Factors”, “Forward-Looking Statements”, “Cautionary Statement Regarding Forward-Looking Statements”, “Special Note Regarding on Forward Looking Statements” or “Note Regarding Forward Looking Information” or containing a description or explanation of “Forward-Looking Statements” or any other disclosures in any Allergan Company SEC Document or AbbVie Parent SEC Document that are cautionary, predictive or forward-looking in nature be deemed to be an exception to (or a disclosure for purposes of or otherwise qualifyof) any representations and warranties of any Party party contained in this Agreement.

Disclosure Schedule References and SEC Document References. (a) The Parties parties hereto agree that each section or subsection of the Allergan Company Disclosure Schedule or the AbbVie Parent Disclosure Schedule, as applicable, shall be deemed to qualify the corresponding section or subsection of this Agreement, irrespective of whether or not any particular section or subsection of this Agreement specifically refers to the Allergan Company Disclosure Schedule or the AbbVie Parent Disclosure Schedule, as applicable. The Parties parties hereto further agree that (other than with respect to any items disclosed in Section 6.1(A)(k4.18(a) of the Allergan Disclosure Schedule or Section 6.2(A)(h) of the AbbVie Company Disclosure Schedule, for which an explicit reference in any other section shall be required in order to apply to such other section) disclosure of any item, matter or event in any particular section or subsection of either the Allergan Company Disclosure Schedule or the AbbVie Parent Disclosure Schedule shall be deemed disclosure with respect to any other section or subsection of the Allergan Company Disclosure Schedule or the AbbVie Parent Disclosure Schedule, as applicable, to which the relevance of such disclosure would be reasonably apparent on its faceapparent, notwithstanding the omission of a cross-reference to such other section or subsections. (b) The Parties parties hereto agree that in no event shall any disclosure contained in any part of any Allergan Company SEC Document or AbbVie Parent SEC Document entitled “Risk Factors”, “Forward-Cautionary Note Regarding Forward Looking Statements”, “Cautionary Statement Regarding Forward-Looking Statements”, ” or “Special Note Regarding Forward Looking Statements” or containing a description or explanation of “Note Regarding Forward Forward-Looking Statements” or any other disclosures in any Allergan Company SEC Document or AbbVie Parent SEC Document that are cautionary, predictive or forward-looking in nature be deemed to be an exception to (or a disclosure for purposes of or otherwise qualifyof) any representations and warranties of any Party party contained in this Agreement.

Disclosure Schedule References and SEC Document References. (a) The Parties parties hereto agree that each section or subsection of the Allergan Company Disclosure Schedule or the AbbVie Parent Disclosure Schedule, as applicable, shall be deemed to be an exception to and to qualify (or, as applicable, a disclosure for purposes of), the corresponding section or subsection of this Agreement, irrespective of whether or not any particular section or subsection of this Agreement specifically refers to the Allergan Company Disclosure Schedule or the AbbVie Parent Disclosure Schedule, as applicable. The Parties parties hereto further agree that (other than with respect to any items disclosed in Section 6.1(A)(k4.20(a) of the Allergan Disclosure Schedule or Section 6.2(A)(h) of the AbbVie Company Disclosure Schedule, for which an explicit reference in any other section shall be required in order to apply to such other section) disclosure of any item, matter or event in any particular section or subsection of either the Allergan Company Disclosure Schedule or the AbbVie Parent Disclosure Schedule shall be deemed disclosure with respect to any other section or subsection of the Allergan Company Disclosure Schedule or the AbbVie Parent Disclosure Schedule, as applicable, to which the relevance of such disclosure would be reasonably apparent on its faceface to a reasonable person without any independent knowledge regarding the matter(s) so disclosed, notwithstanding the omission of a cross-reference to such other section or subsections. (b) The Parties parties hereto agree that in no event shall any disclosure (other than statements of historical fact) contained in any part of any Allergan Company SEC Document or AbbVie Parent SEC Document entitled “Risk Factors”, ,” “Forward-Looking Statements”, ,” “Cautionary Statement Regarding Forward-Looking Statements”, ,” “Special Note Regarding on Forward Looking Statements” or “Note Regarding Forward Looking Information” or containing a description or explanation of “Forward-Looking Statements” or any other disclosures in any Allergan Company SEC Document or AbbVie Parent SEC Document that are cautionary, predictive or forward-looking in nature be deemed to be an exception to (or a disclosure for purposes of or otherwise qualifyof) any representations and warranties of any Party party contained in this Agreement.

Disclosure Schedule References and SEC Document References. (a) The Parties parties hereto agree that each section or subsection of the Allergan Company Disclosure Schedule or the AbbVie Parent Disclosure Schedule, as applicable, shall be deemed to qualify the corresponding section or subsection of this Agreement, irrespective of whether or not any particular section or subsection of this Agreement specifically refers to the Allergan Company Disclosure Schedule or the AbbVie Parent Disclosure Schedule, as applicable. The Parties parties hereto further agree that (other than with respect to any items disclosed in Section 6.1(A)(k4.18(a) of the Allergan Disclosure Schedule or Section 6.2(A)(h) of the AbbVie Company Disclosure Schedule, for which an explicit reference in any other section shall be required in order to apply to such other section) disclosure of any item, matter or event in any particular section or subsection of either the Allergan Company Disclosure Schedule or the AbbVie Parent Disclosure Schedule shall be deemed disclosure with respect to any other section or subsection of the Allergan Company Disclosure Schedule or the AbbVie Parent Disclosure Schedule, as applicable, to which the relevance of such disclosure would be reasonably apparent on its faceapparent, notwithstanding the omission of a cross-reference to such other section or subsections. (b) The Parties parties hereto agree that in no event shall any disclosure contained in any part of any Allergan Company SEC Document or AbbVie Parent SEC Document entitled “Risk Factors”, “Forward-Looking Statements”, “Cautionary Statement Regarding Forward-Looking Statements”, “Special Note Regarding on Forward Looking Statements” or “Note Regarding Forward Looking Information” or containing a description or explanation of “Forward-Looking Statements” or any other disclosures in any Allergan Company SEC Document or AbbVie Parent SEC Document that are cautionary, predictive or forward-looking in nature be deemed to be an exception to (or a disclosure for purposes of or otherwise qualifyof) any representations and warranties of any Party party contained in this Agreement.

Disclosure Schedule References and SEC Document References. (a) The Parties parties hereto agree that each section or subsection of the Allergan Company Disclosure Schedule or the AbbVie Parent Disclosure Schedule, as applicable, shall be deemed to qualify the corresponding section or subsection of this Agreement, irrespective of whether or not any particular section or subsection of this Agreement specifically refers to the Allergan Company Disclosure Schedule or the AbbVie Parent Disclosure Schedule, as applicable. The Parties parties hereto further agree that (other than with respect to any items disclosed in Section 6.1(A)(k4.18(a) of the Allergan Disclosure Schedule or Section 6.2(A)(h) of the AbbVie Company Disclosure Schedule, for which an explicit reference in any other section shall be required in order to apply to such other section) disclosure of any item, matter or event in any particular section or subsection of either the Allergan Company Disclosure Schedule or the AbbVie Parent Disclosure Schedule shall be deemed disclosure with respect to any other section or subsection of the Allergan Company Disclosure Schedule or the AbbVie Parent Disclosure Schedule, as applicable, to which the relevance of such disclosure would be reasonably apparent on its faceapparent, notwithstanding the omission of a cross-reference to such other section or subsections. (b) The Parties parties hereto agree that in no event shall any disclosure contained in any part of any Allergan Company SEC Document or AbbVie Parent SEC Document entitled “Risk Factors”, “Forward-Looking Statements”, “Cautionary Statement Note Regarding Forward-Looking Statements”, ” or “Special Note Regarding Forward Looking Statements” or containing a description or explanation of “Note Regarding Forward Forward-Looking Statements” or any other disclosures in any Allergan Company SEC Document or AbbVie Parent SEC Document that are cautionary, predictive or forward-looking in nature be deemed to be an exception to (or a disclosure for purposes of or otherwise qualifyof) any representations and warranties of any Party party contained in this Agreement.

Disclosure Schedule References and SEC Document References. (a) The Parties parties hereto agree that each section or subsection of the Allergan Company Disclosure Schedule or the AbbVie Parent Disclosure Schedule, as applicable, shall be deemed to qualify the corresponding section or subsection of this Agreement, irrespective of whether or not any particular section or subsection of this Agreement specifically refers to the Allergan Company Disclosure Schedule or the AbbVie Parent Disclosure Schedule, as applicable. The Parties parties hereto further agree that (other than with respect to any items disclosed in Section 6.1(A)(k) of the Allergan Disclosure Schedule or Section 6.2(A)(h) of the AbbVie Disclosure Schedule, for which an explicit reference in any other section shall be required in order to apply to such other section) disclosure of any item, matter or event in any particular section or subsection of either the Allergan Company Disclosure Schedule or the AbbVie Parent Disclosure Schedule shall be deemed disclosure with respect to any other section or subsection of the Allergan Company Disclosure Schedule or the AbbVie Parent Disclosure Schedule, as applicable, to which the relevance of such disclosure would be reasonably apparent on its faceapparent, notwithstanding the omission of a cross-reference to such other section or subsections. (b) The Parties parties hereto agree that that, for purpose of clause (i) of the lead-in to Article IV and clause (i) of the lead-in to Article V, as applicable, in no event shall any disclosure contained in any part of any Allergan Company SEC Document or AbbVie Parent SEC Document entitled “Risk Factors”, “Forward-Looking Statements”, “Cautionary Statement Regarding Forward-Looking Statements”, “Special Note Regarding Forward Looking Statements” or “Note Regarding Forward Looking Statements” or any other disclosures in any Allergan Company SEC Document or AbbVie Parent SEC Document that are cautionary, predictive or forward-looking in nature be deemed to be an exception to (or a disclosure for purposes of or otherwise qualify) any representations and warranties of any Party party contained in this Agreement.

Disclosure Schedule References and SEC Document References. (a) The Parties hereto agree that each section or subsection of the Allergan Company Disclosure Schedule or the AbbVie Parent Disclosure Schedule, as applicable, shall be deemed to qualify the corresponding section or subsection of this Agreement, irrespective of whether or not any particular section or subsection of this Agreement specifically refers to the Allergan Company Disclosure Schedule or the AbbVie Parent Disclosure Schedule, as applicable. The Parties hereto further agree that (other than with respect to any items disclosed in Section 6.1(A)(k) of the Allergan Disclosure Schedule or Section 6.2(A)(h) of the AbbVie Disclosure Schedule, for which an explicit reference in any other section shall be required in order to apply to such other section) disclosure of any item, matter or event in any particular section or subsection of either the Allergan Company Disclosure Schedule or the AbbVie Parent Disclosure Schedule shall be deemed disclosure with respect to any other section or subsection of the Allergan Company Disclosure Schedule or the AbbVie Parent Disclosure Schedule, as applicable, to which the relevance of such disclosure would be reasonably apparent on its faceapparent, notwithstanding the omission of a cross-reference to such other section or subsections. (b) The Parties hereto agree that in no event shall any disclosure contained in any part of any Allergan Company SEC Document or AbbVie Parent SEC Document entitled “Risk Factors”, “Forward-Looking Statements”, “Cautionary Statement Regarding Forward-Looking Statements”, “Special Note Regarding Forward Looking Statements” or “Note Regarding Forward Looking Statements” or any other disclosures in any Allergan Company SEC Document or AbbVie Parent SEC Document that are cautionary, predictive or forward-looking in nature be deemed to be an exception to (or a disclosure for purposes of or otherwise qualify) any representations and warranties of any Party contained in this Agreement.

Disclosure Schedule References and SEC Document References. (a) The Parties parties hereto agree that each section or subsection of the Allergan Company Disclosure Schedule or the AbbVie Parent Disclosure Schedule, as applicable, shall be deemed to be an exception to and to qualify (or, as applicable, a disclosure for purposes of), the corresponding section or subsection of this Agreement, irrespective of whether or not any particular section or subsection of this Agreement specifically refers to the Allergan Company Disclosure Schedule or the AbbVie Parent Disclosure Schedule, as applicable. The Parties parties hereto further agree that (other than with respect to any items disclosed in Section 6.1(A)(k‎4.20(a) of the Allergan Disclosure Schedule or Section 6.2(A)(h) of the AbbVie Company Disclosure Schedule, for which an explicit reference in any other section shall be required in order to apply to such other section) disclosure of any item, matter or event in any particular section or subsection of either the Allergan Company Disclosure Schedule or the AbbVie Parent Disclosure Schedule shall be deemed disclosure with respect to any other section or subsection of the Allergan Company Disclosure Schedule or the AbbVie Parent Disclosure Schedule, as applicable, to which the relevance of such disclosure would be reasonably apparent on its faceface to a reasonable person without any independent knowledge regarding the matter(s) so disclosed, notwithstanding the omission of a cross-reference to such other section or subsections. (b) The Parties parties hereto agree that in no event shall any disclosure (other than statements of historical fact) contained in any part of any Allergan Company SEC Document or AbbVie Parent SEC Document entitled “Risk Factors”, ,” “Forward-Looking Statements”, ,” “Cautionary Statement Regarding Forward-Looking Statements”, ,” “Special Note Regarding on Forward Looking Statements” or “Note Regarding Forward Looking Information” or containing a description or explanation of “Forward-Looking Statements” or any other disclosures in any Allergan Company SEC Document or AbbVie Parent SEC Document that are cautionary, predictive or forward-looking in nature be deemed to be an exception to (or a disclosure for purposes of or otherwise qualifyof) any representations and warranties of any Party party contained in this Agreement.

Disclosure Schedule References and SEC Document References. (a) The Parties parties hereto agree that each section or subsection of the Allergan Company Disclosure Schedule or the AbbVie Parent Disclosure Schedule, as applicable, shall be deemed to qualify the corresponding section or subsection of this Agreement, irrespective of whether or not any particular section or subsection of this Agreement specifically refers to the Allergan Company Disclosure Schedule or the AbbVie Parent Disclosure Schedule, as applicable. The Parties parties hereto further agree that (other than with respect to any items disclosed in Section 6.1(A)(k4. I 8(a) of the Allergan Disclosure Schedule or Section 6.2(A)(h) of the AbbVie Company Disclosure Schedule, for which an explicit reference in any other section shall be required in order to apply to such other section) disclosure of any item, . matter or event in any particular section or subsection of either the Allergan Company Disclosure Schedule or the AbbVie Parent Disclosure Schedule shall be deemed disclosure with respect to any other section or subsection of the Allergan Company Disclosure Schedule or the AbbVie Parent Disclosure Schedule, as applicable, . to which the relevance of such disclosure would be reasonably apparent on its face, apparent. notwithstanding the omission of a ofa cross-reference to such other section or subsections. (b) The Parties parties hereto agree that in no event shall any disclosure contained in any part of any Allergan Company SEC Document or AbbVie Parent SEC Document entitled “"Risk Factors”, “". "Forward-Looking Statements”", “"Cautionary Statement Regarding Forward-Looking Statements”, “". "Special Note Regarding on Forward Looking Statements” " or “Note Regarding "Forward Looking Information" or containing a description or explanation of"Forward-Looking Statements” " or any other 106 disclosures in any Allergan Company SEC Document or AbbVie Parent SEC Document that are arc cautionary, . predictive or forward-looking in nature be deemed to be an exception to (or a disclosure for purposes of or otherwise qualifyof) any representations and warranties of any Party party contained in this Agreement.

Disclosure Schedule References and SEC Document References. (a) The Parties parties hereto agree that each section or subsection of the Allergan Company Disclosure Schedule or the AbbVie Parent Disclosure Schedule, as applicable, shall be deemed to be an exception to and to qualify (or, as applicable, a disclosure for purposes of), the corresponding section or subsection of this Agreement, irrespective of whether or not any particular section or subsection of this Agreement specifically refers to the Allergan Company Disclosure Schedule or the AbbVie Parent Disclosure Schedule, as applicable. The Parties parties hereto further agree that (other than with respect to any items disclosed in Section 6.1(A)(k‎Section 4.20(a) of the Allergan Disclosure Schedule or Section 6.2(A)(h) of the AbbVie Company Disclosure Schedule, for which an explicit reference in any other section shall be required in order to apply to such other section) disclosure of any item, matter or event in any particular section or subsection of either the Allergan Company Disclosure Schedule or the AbbVie Parent Disclosure Schedule shall be deemed disclosure with respect to any other section or subsection of the Allergan Company Disclosure Schedule or the AbbVie Parent Disclosure Schedule, as applicable, to which the relevance of such disclosure would be reasonably apparent on its faceface to a reasonable person without any independent knowledge regarding the matter(s) so disclosed, notwithstanding the omission of a cross-reference to such other section or subsections. (b) The Parties parties hereto agree that in no event shall any disclosure (other than statements of historical fact) contained in any part of any Allergan Company SEC Document or AbbVie Parent SEC Document entitled “Risk Factors”, ,” “Forward-Looking Statements”, ,” “Cautionary Statement Regarding Forward-Looking Statements”, ,” “Special Note Regarding on Forward Looking Statements” or “Note Regarding Forward Looking Information” or containing a description or explanation of “Forward-Looking Statements” or any other disclosures in any Allergan Company SEC Document or AbbVie Parent SEC Document that are cautionary, predictive or forward-looking in nature be deemed to be an exception to (or a disclosure for purposes of or otherwise qualifyof) any representations and warranties of any Party party contained in this Agreement.

Disclosure Schedule References and SEC Document References. (a) The Parties parties hereto agree that each section or subsection of the Allergan Company Disclosure Schedule or the AbbVie Parent Disclosure Schedule, as applicable, shall be deemed to qualify the corresponding section or subsection of this Agreement, irrespective of whether or not any particular section or subsection of this Agreement specifically refers to the Allergan Company Disclosure Schedule or the AbbVie Parent Disclosure Schedule, as applicable. The Parties parties hereto further agree that (other than with respect to any items disclosed in Section 6.1(A)(k4.15(a) of the Allergan Disclosure Schedule or Section 6.2(A)(h) of the AbbVie Company Disclosure Schedule, for which an explicit reference in any other section shall be required in order to apply to such other section) disclosure of any item, matter or event in any particular section or subsection of either the Allergan Company Disclosure Schedule or the AbbVie Parent Disclosure Schedule shall be deemed disclosure with respect to any other section or subsection of the Allergan Company Disclosure Schedule or the AbbVie Parent Disclosure Schedule, as applicable, to which the relevance of such disclosure would be reasonably apparent on its faceapparent, notwithstanding the omission of a cross-reference to such other section or subsections. (b) The Parties parties hereto agree that in no event shall any disclosure contained in any part of any Allergan SEC Document or AbbVie Company SEC Document entitled “Risk Factors”, “Forward-Looking Statements”, “Cautionary Statement Regarding Forward-Looking Statements”, “Special Note Regarding Forward Looking Statements” or “Note Regarding Forward Looking Statements” or any other disclosures in any Allergan SEC Document or AbbVie Company SEC Document that are cautionary, predictive or forward-looking in nature be deemed to be an exception to (or a disclosure for purposes of or otherwise qualify) any representations and warranties of any Party party contained in this Agreement.